Renate Huebner was diagnosed with pulmonary fibrosis at the age of 65 in August 2012. With 10 children and 38…
Articles by Patrícia Silva, PhD
Pulmonary fibrosis is a rare but life-threatening disease, for which there is currently no cure. One of the…
Spherix Global Insights, GmbH, a business intelligence and market research company based on Switzerland, recently reported a study revealing…
Boehringer Ingelheim recently announced the enrollment of the first patient in its Phase 3 clinical trial, called SENSCIS (Safety and…
Throughout 2015, Pulmonary Fibrosis News reported on studies in the field of pulmonary fibrosis care, treatment and disease management, as well as…
DS Biopharma, headquartered in Dublin, Ireland, and focused on therapies for inflammatory and fibrotic skin and pulmonary disorders, recently…
The University of Cincinnati (UC) Medical Center is among the 19 medical centers recently invited after careful review to become…
The University of Virginia Health System (UVA) recently joined the Pulmonary Fibrosis Foundation (PFF)’s Care Center Network, making…
Researchers at the University of Miami (UM), led by Assistant Professor Ashutosh Agarwal, are developing functional organs able to…
Afferent Pharmaceuticals, a biotechnology company dedicated to therapies for neurogenic disorders, recently announced the beginning of a Phase 2…